ARLINGTON, Texas (AP) — The Texas Rangers said Tuesday night an MRI on Jacob deGrom's right knee showed no issues, a few hours after the two-time Cy Young Award winner indicated everything checked out OK after his most recent start.

DeGrom experienced some mild knee discomfort before he pitched Monday night against Seattle, and was limited to 78 pitches over five innings because the Rangers didn't want to push the 37-year-old right-hander too hard. He allowed only one hit in his 250th career start, a first-inning homer to Cal Raleigh in the Rangers' 2-1 win. He struck out six and walked one before leaving with the game tied 1-1.

Copyright 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

Recommended for you

(0) comments

Welcome to the discussion.

Keep the discussion civilized. Absolutely NO personal attacks or insults directed toward writers, nor others who make comments.
Keep it clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't threaten. Threats of harming another person will not be tolerated.
Be truthful. Don't knowingly lie about anyone or anything.
Be proactive. Use the 'Report' link on each comment to let us know of abusive posts.
PLEASE TURN OFF YOUR CAPS LOCK.
Anyone violating these rules will be issued a warning. After the warning, comment privileges can be revoked.

Thank you for visiting the Daily Journal.

Please purchase a Premium Subscription to continue reading. To continue, please log in, or sign up for a new account.

We offer one free story view per month. If you register for an account, you will get two additional story views. After those three total views, we ask that you support us with a subscription.

A subscription to our digital content is so much more than just access to our valuable content. It means you’re helping to support a local community institution that has, from its very start, supported the betterment of our society. Thank you very much!

Want to join the discussion?

Only subscribers can view and post comments on articles.

Already a subscriber? Login Here